Phytoremediation using native plants

The unprecedented growth in industrialization has significantly increased pollution in the environment causing public health concerns. The remediation of various contaminated environmental matrices presents a global challenge. Phytoremediation using native plants can serve a dual purpose of site remediation and ecological restoration. Native plants provide an ideal residence for microbial community in their rhizosphere with enzymatic ability to accumulate, stabilize, biodegrade or volatilize various inorganic and organic contaminants. A case study that compared a native plant, Chromolaena odorata, from crude oil-polluted land in Nigeria against a referenced plant, Medicago sativa, for polycyclic aromatic hydrocarbons (PAHs) remediation is presented in this chapter. It was observed that the native plant thrived, tolerated and degraded PAHs better than the reference plant but with no significant difference in PAH degradation. The use of plants is well suited to its natural contaminated area and solar-driven, prevents erosion and eliminates secondary airborne and waterborne waste but with some challenges. Phytoremediation using native species may be effective and efficient than its non-native counterparts, and it is ecologically safer, cheaper, aesthetically pleasing, socially acceptable and easier to cultivate. Native plants in phytoremediation can be further enhanced and improved using molecular techniques to optimize the harvest time, reduce growth duration and increase biomass production and root depth

Characteristics of Susac syndrome: a review of all reported cases

In Susac syndrome, occlusions of microvessels-presumed to be mediated by an autoimmune response to an as yet unknown antigen--lead to a characteristic clinical triad of CNS dysfunction, branch retinal artery occlusions, and sensorineural hearing impairment. Susac syndrome is considered a rare but important differential diagnosis in numerous neurological, psychiatric, ophthalmological, and ear, nose and throat disorders. Improved understanding of this disorder is crucial, therefore, to ensure that patients receive appropriate treatment and care. Current knowledge on Susac syndrome is largely based on reports of single patients, small case series, and nonsystematic reviews. The aim of this Review is to extend these previous, primarily anecdotal findings by compiling data from all 304 cases of Susac syndrome that have been published worldwide, which were identified following a literature search with predefined search, inclusion and exclusion criteria. From this data, we present an overview of demographic, clinical and diagnostic data on Susac syndrome, providing a reliable basis for our current understanding of this rare disease. Where possible, we make recommendations for clinical diagnosis, differential diagnosis, and management of patients with suspected Susac syndrome